v3.26.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenues
Operating expenses:    
General and administrative 1,300,956 1,333,930
Research and development 83,040 373,271
Stock-based compensation 1,040,594 2,609,786
Total operating expenses 2,424,590 4,316,987
Interest expense, net 4,005 3,840
Net loss $ (2,428,595) $ (4,320,827)
Net loss per share, basic $ (0.13) $ (0.24)
Net loss per share, diluted $ (0.13) $ (0.24)
Weighted average number of common shares outstanding during the period- basic 18,562,592 17,940,639
Weighted average number of common shares outstanding during the period- diluted 18,562,592 17,940,639